366 related articles for article (PubMed ID: 34117129)
1. Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
Anand S; Montez-Rath ME; Han J; Garcia P; Cadden L; Hunsader P; Kerschmann R; Beyer P; Dittrich M; Block GA; Boyd SD; Parsonnet J; Chertow GM
J Am Soc Nephrol; 2021 Oct; 32(10):2435-2438. PubMed ID: 34117129
[No Abstract] [Full Text] [Related]
2. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
[TBL] [Abstract][Full Text] [Related]
3. Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19.
Chan L; Fuca N; Zeldis E; Campbell KN; Shaikh A
Clin J Am Soc Nephrol; 2021 Aug; 16(8):1258-1260. PubMed ID: 34031182
[No Abstract] [Full Text] [Related]
4. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
5. Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine.
Cancer Discov; 2021 Sep; 11(9):2122. PubMed ID: 34272229
[TBL] [Abstract][Full Text] [Related]
6. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
[No Abstract] [Full Text] [Related]
7. Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers.
Debes AK; Xiao S; Colantuoni E; Egbert ER; Caturegli P; Gadala A; Milstone AM
JAMA Intern Med; 2021 Dec; 181(12):1660-1662. PubMed ID: 34398173
[TBL] [Abstract][Full Text] [Related]
8. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
Zitt E; Davidovic T; Schimpf J; Abbassi-Nik A; Mutschlechner B; Ulmer H; Benda MA; Sprenger-Mähr H; Winder T; Lhotta K
Front Immunol; 2021; 12():704773. PubMed ID: 34220867
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients.
Melin J; Svensson MK; Albinsson B; Winqvist O; Pauksens K
BMC Immunol; 2021 Oct; 22(1):70. PubMed ID: 34666683
[TBL] [Abstract][Full Text] [Related]
10. On reaching herd immunity during the COVID-19 pandemic and further issues.
Pandolfi S; Chirumbolo S
J Med Virol; 2022 Jan; 94(1):24-25. PubMed ID: 34491592
[No Abstract] [Full Text] [Related]
11. SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
Alidjinou EK; Gaillot O; Guigon A; Tinez C; Lazrek M; Bocket L; Engelmann I; Hober D
Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115565. PubMed ID: 34731684
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis.
Garcia P; Han J; Montez-Rath ME; Sun S; Shang T; Parsonnet J; Chertow GM; Anand S; Schiller B; Abra G
Clin J Am Soc Nephrol; 2022 Jul; 17(7):1036-1038. PubMed ID: 35383042
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.
Abu Jabal K; Ben-Amram H; Beiruti K; Brimat I; Abu Saada A; Bathish Y; Sussan C; Zarka S; Edelstein M
Epidemiol Infect; 2021 Aug; 149():e239. PubMed ID: 34399868
[TBL] [Abstract][Full Text] [Related]
14. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.
Boyarsky BJ; Chiang TP; Teles AT; Greenberg RS; Krach MR; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL; Werbel AWA
Transplantation; 2021 Oct; 105(10):e137-e138. PubMed ID: 34241987
[No Abstract] [Full Text] [Related]
15. Scent of a vaccine.
Lund FE; Randall TD
Science; 2021 Jul; 373(6553):397-399. PubMed ID: 34437109
[No Abstract] [Full Text] [Related]
16. Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance.
Pedersen RM; Tornby DS; Bistrup C; Johansen IS; Andersen TE; Justesen US
Clin Microbiol Infect; 2021 Sep; 27(9):1371-1373. PubMed ID: 34111582
[No Abstract] [Full Text] [Related]
17. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W
Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccines and kidney disease.
Windpessl M; Bruchfeld A; Anders HJ; Kramer H; Waldman M; Renia L; Ng LFP; Xing Z; Kronbichler A
Nat Rev Nephrol; 2021 May; 17(5):291-293. PubMed ID: 33558753
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
[No Abstract] [Full Text] [Related]
20. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
